000950 重药控股
已收盘 06-15 15:00:00
资讯
新帖
简况
重药控股（000950）披露关于回购股份进展的公告，6月1日股价上涨0.34%
证券之星 · 06-01
重药控股（000950）披露关于回购股份进展的公告，6月1日股价上涨0.34%
股市必读：重药控股（000950）5月28日董秘有最新回复
证券之星 · 05-29
股市必读：重药控股（000950）5月28日董秘有最新回复
重药控股最新公告：参股子公司签订许可协议
证券之星 · 05-28
重药控股最新公告：参股子公司签订许可协议
重药控股：公司推行的双职董事长制度，是公司为深化改革、优化治理、集约配置管理人才推出的试点制度
证券之星 · 05-28
重药控股：公司推行的双职董事长制度，是公司为深化改革、优化治理、集约配置管理人才推出的试点制度
重药控股（000950）披露参股子公司药品获注册批准公告，5月25日股价上涨0.16%
证券之星 · 05-25
重药控股（000950）披露参股子公司药品获注册批准公告，5月25日股价上涨0.16%
重药控股最新公告：参股子公司左氧氟沙星注射液获注册批准
证券之星 · 05-22
重药控股最新公告：参股子公司左氧氟沙星注射液获注册批准
营收增长靠“铺网点”，利润薄如纸，重药控股业绩增长背后的隐忧
微博财经-财道工作室 · 05-18
营收增长靠“铺网点”，利润薄如纸，重药控股业绩增长背后的隐忧
重药控股（000950）披露2025年年度股东会决议公告，5月15日股价下跌1.04%
证券之星 · 05-15
重药控股（000950）披露2025年年度股东会决议公告，5月15日股价下跌1.04%
异动快报：重药控股（000950）5月12日10点12分触及涨停板
证券之星 · 05-12
异动快报：重药控股（000950）5月12日10点12分触及涨停板
股市必读：重药控股（000950）5月7日披露最新机构调研信息
证券之星 · 05-08
股市必读：重药控股（000950）5月7日披露最新机构调研信息
重药控股（000950）披露回购股份进展公告，5月6日股价上涨1.21%
证券之星 · 05-06
重药控股（000950）披露回购股份进展公告，5月6日股价上涨1.21%
重药控股最新公告：参股子公司硝普钠注射液获国家药监局注册批准
证券之星 · 05-06
重药控股最新公告：参股子公司硝普钠注射液获国家药监局注册批准
重药控股：本次薪酬变动主要系报告期内在公司领取薪酬的董事、高级管理人员发生4人次变动所致
证券之星 · 04-29
重药控股：本次薪酬变动主要系报告期内在公司领取薪酬的董事、高级管理人员发生4人次变动所致
重药控股：本次薪酬变动主要系报告期内在公司领取薪酬的董事、高级管理人员发生4人次变动所致
证券之星 · 04-28
重药控股：本次薪酬变动主要系报告期内在公司领取薪酬的董事、高级管理人员发生4人次变动所致
30余家药企一季报出炉：有人狂赚有人亏 行业分化加剧
21世纪经济报道 · 04-27
30余家药企一季报出炉：有人狂赚有人亏 行业分化加剧
股市必读：重药控股年报 - 第四季度单季净利润同比增长129.30%
证券之星 · 04-27
股市必读：重药控股年报 - 第四季度单季净利润同比增长129.30%
重药控股（000950）披露2025年度涉及财务公司关联交易的存款、贷款等金融业务专项说明，4月24日股价下跌2.97%
证券之星 · 04-24
重药控股（000950）披露2025年度涉及财务公司关联交易的存款、贷款等金融业务专项说明，4月24日股价下跌2.97%
重药控股(000950.SZ)发布一季度业绩，归母净利润1.71亿元，同比增长36.33%
智通财经 · 04-24
重药控股(000950.SZ)发布一季度业绩，归母净利润1.71亿元，同比增长36.33%
4月10日重药控股（000950）龙虎榜数据：机构净卖出1.29亿元（3日），北向资金净卖出789.68万元（3日）
证券之星 · 04-10
4月10日重药控股（000950）龙虎榜数据：机构净卖出1.29亿元（3日），北向资金净卖出789.68万元（3日）
重药控股：公司按照《企业会计准则》相关规定对联营企业进行相应的会计处理
证券之星 · 04-08
重药控股：公司按照《企业会计准则》相关规定对联营企业进行相应的会计处理
公司概况
公司名称：
重药控股股份有限公司
所属行业：
批发业
上市日期：
1999-09-16
主营业务：
重药控股股份有限公司的主营业务是医药商业、仓储物流、医药工业和研发等业务。公司的主要产品是药品、医疗器械、中药饮片、保健产品。
发行价格：
4.63
{"stockData":{"symbol":"000950","market":"SZ","secType":"STK","nameCN":"重药控股","latestPrice":5.32,"timestamp":1781507019000,"preClose":5.25,"halted":0,"volume":21928414,"delay":0,"changeRate":0.0133,"floatShares":1728000000,"shares":1728000000,"eps":0.2501,"marketStatus":"已收盘","change":0.07,"latestTime":"06-15 15:00:00","open":5.27,"high":5.37,"low":5.26,"amount":116000000,"amplitude":0.021,"askPrice":5.32,"askSize":880,"bidPrice":5.31,"bidSize":1987,"shortable":0,"etf":0,"ttmEps":0.2501,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1781573400000},"marketStatusCode":5,"adr":0,"adjPreClose":5.25,"symbolType":"stock","openAndCloseTimeList":[[1781487000000,1781494200000],[1781499600000,1781506800000]],"highLimit":5.78,"lowLimit":4.73,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":1728184696,"isCdr":false,"pbRate":0.78,"roa":"--","peRate":21.271491,"roe":"1.47%","epsLYR":0.22,"committee":0.025835,"marketValue":9194000000,"turnoverRate":0.0127,"status":0,"floatMarketCap":9194000000},"requestUrl":"/m/hq/s/000950/wiki","defaultTab":"wiki","newsList":[{"id":"2640895007","title":"重药控股（000950）披露关于回购股份进展的公告，6月1日股价上涨0.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2640895007","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640895007?lang=zh_cn&edition=full","pubTime":"2026-06-01 22:44","pubTimestamp":1780325060,"startTime":"0","endTime":"0","summary":"截至2026年6月1日收盘，重药控股报收于5.83元，较前一交易日上涨0.34%，最新总市值为100.75亿元。该股当日开盘5.85元，最高5.86元，最低5.72元，成交额达1.77亿元，换手率为1.77%。近日，重药控股发布《关于回购股份进展的公告》。公告显示，公司于2025年7月10日和7月28日分别召开董事会及临时股东会，审议通过回购公司股份的议案。回购进展符合相关法规及公司方案要求。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060100041460.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000950","BK0071","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639660690","title":"股市必读：重药控股（000950）5月28日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2639660690","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639660690?lang=zh_cn&edition=full","pubTime":"2026-05-29 01:17","pubTimestamp":1779988630,"startTime":"0","endTime":"0","summary":"截至2026年5月28日收盘，重药控股报收于5.77元，下跌1.54%，换手率1.64%，成交量28.39万手，成交额1.64亿元。来自公司公告汇总：重药控股参股子公司药友制药获授纬利妥米单克隆抗体在中国境内及港澳台地区的独占开发与商业化权利。协议涉及首付款至多3亿元、上市里程碑至多2.5亿元、技转里程碑至多5000万元，并根据年度净销售额支付销售里程碑及提成。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052900001582.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","000950","BK0071"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638662780","title":"重药控股最新公告：参股子公司签订许可协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2638662780","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638662780?lang=zh_cn&edition=full","pubTime":"2026-05-28 18:39","pubTimestamp":1779964797,"startTime":"0","endTime":"0","summary":"重药控股(000950.SZ)公告称，公司参股子公司药友制药与智翔金泰签订许可协议，获授予GR1803注射液(纬利妥米单抗)在中国境内及港澳台地区临床开发、商业化的独占权利及生产工艺研究、生产的排他权利。药友制药将支付至多6亿元的首付款、上市里程碑及技转里程碑款项，并基于净销售额支付销售里程碑及销售提成。该产品目前处于新药上市申请审评阶段，但存在研发及商业化不确定性风险。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052800036079.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","BK0071","000950"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638668392","title":"重药控股：公司推行的双职董事长制度，是公司为深化改革、优化治理、集约配置管理人才推出的试点制度","url":"https://stock-news.laohu8.com/highlight/detail?id=2638668392","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638668392?lang=zh_cn&edition=full","pubTime":"2026-05-28 15:15","pubTimestamp":1779952518,"startTime":"0","endTime":"0","summary":"证券之星消息，重药控股(000950)05月28日在投资者关系平台上答复投资者关心的问题。投资者提问：请问贵公司的双职董事长制度是一种什么的制度，麻烦介绍下重药控股回复：公司推行的双职董事长制度，是公司为深化改革、优化治理、集约配置管理人才推出的试点制度。感谢您的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052800021935.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0071","BK0250","000950"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638312855","title":"重药控股（000950）披露参股子公司药品获注册批准公告，5月25日股价上涨0.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2638312855","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638312855?lang=zh_cn&edition=full","pubTime":"2026-05-25 17:41","pubTimestamp":1779702090,"startTime":"0","endTime":"0","summary":"截至2026年5月25日收盘，重药控股报收于6.19元，较前一交易日上涨0.16%，最新总市值为106.97亿元。该股当日开盘6.15元，最高6.27元，最低6.08元，成交额达1.7亿元，换手率为1.6%。近日，重药控股股份有限公司披露《关于参股子公司药品获注册批准的公告》。该药品注册分类为化学药品3类，规格为20ml:0.5g，上市许可持有人为重庆药友制药有限责任公司，批准文号为国药准字H20264412。该事项将丰富参股子公司产品线，但后续销售存在不确定性。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052500025156.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0071","000950","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2637881315","title":"重药控股最新公告：参股子公司左氧氟沙星注射液获注册批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2637881315","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2637881315?lang=zh_cn&edition=full","pubTime":"2026-05-22 18:30","pubTimestamp":1779445856,"startTime":"0","endTime":"0","summary":"重药控股(000950.SZ)公告称，公司参股子公司重庆药友制药的左氧氟沙星注射液药品注册申请获国家药监局批准，用于多种敏感细菌感染。以上内容为证券之星据公开信息整理，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052200036848.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000950","BK0250","BK0071"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636021664","title":"营收增长靠“铺网点”，利润薄如纸，重药控股业绩增长背后的隐忧","url":"https://stock-news.laohu8.com/highlight/detail?id=2636021664","media":"微博财经-财道工作室","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636021664?lang=zh_cn&edition=full","pubTime":"2026-05-18 17:04","pubTimestamp":1779095040,"startTime":"0","endTime":"0","summary":"财报显示，2025年公司营业收入824.47亿元，同比增长2.34%。另一方面，去年，重药控股药品主业的停滞，靠器械增量填补。年报显示，重药控股2025年器械营收146.91亿元，同比增长15.24%，但毛利率从11.26%急跌至5.52%，下滑5.74个百分点。不仅如此，重药控股的高毛利品类对业绩提升有限。另一方面，重药控股的应收账款逐年增加，引发对其回款能力下滑的猜疑。应收账款增加的同时，重药控股坏账也在增加。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/wbstock/2026-05-18/doc-inhyiewm2897753.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["000950"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635707780","title":"重药控股（000950）披露2025年年度股东会决议公告，5月15日股价下跌1.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635707780","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635707780?lang=zh_cn&edition=full","pubTime":"2026-05-15 17:27","pubTimestamp":1778837277,"startTime":"0","endTime":"0","summary":"截至2026年5月15日收盘，重药控股报收于6.68元，较前一交易日下跌1.04%，最新总市值为115.44亿元。公告显示，公司于2026年5月14日召开2025年年度股东会，会议由董事会召集，采用现场与网络投票结合方式召开，出席股东代表股份占总表决权股份的59.4681%。会议审议通过了2025年度董事会工作报告、2025年年度报告、财务决算报告、2026年度财务预算报告及2025年度利润分配预案等全部议案，所有议案均获通过。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051500031577.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000950","BK0250","BK0071"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634257725","title":"异动快报：重药控股（000950）5月12日10点12分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2634257725","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634257725?lang=zh_cn&edition=full","pubTime":"2026-05-12 10:21","pubTimestamp":1778552463,"startTime":"0","endTime":"0","summary":"证券之星5月12日盘中消息，10点12分重药控股（000950）触及涨停板。其所属行业医药商业目前下跌。领涨股为重药控股。该股为重庆国企改革，医疗耗材供应链SPD，国企改革概念热股，当日重庆国企改革概念上涨0.39%。5月11日的资金流向数据方面，主力资金净流入3452.12万元，占总成交额6.84%，游资资金净流出563.98万元，占总成交额1.12%，散户资金净流出2888.14万元，占总成交额5.72%。近5日资金流向一览见下表：重药控股主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051200012086.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","000950","BK0071"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633712762","title":"股市必读：重药控股（000950）5月7日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2633712762","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633712762?lang=zh_cn&edition=full","pubTime":"2026-05-08 01:28","pubTimestamp":1778174892,"startTime":"0","endTime":"0","summary":"截至2026年5月7日收盘，重药控股报收于5.87元，上涨0.0%，换手率1.77%，成交量30.65万手，成交额1.8亿元。机构调研要点公司于2025年12月11日披露药友制药与上海复星医药产业发展有限公司及辉瑞签订许可协议，目前协议正常履行中。关于参股子公司与辉瑞合作的减肥药项目，公司将依规履行信息披露义务。公司公告汇总重药控股于2025年7月审议通过股份回购方案，拟使用8000万元至1亿元资金回购股份用于减资，价格不超过6.6元/股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050800001515.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000950","BK0071","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633132688","title":"重药控股（000950）披露回购股份进展公告，5月6日股价上涨1.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633132688","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633132688?lang=zh_cn&edition=full","pubTime":"2026-05-06 22:54","pubTimestamp":1778079260,"startTime":"0","endTime":"0","summary":"截至2026年5月6日收盘，重药控股报收于5.87元，较前一交易日上涨1.21%，最新总市值为101.44亿元。该股当日开盘5.81元，最高5.89元，最低5.81元，成交额达1.7亿元，换手率为1.68%。近日，重药控股发布《关于回购股份进展的公告》。公告显示，公司于2025年7月10日和7月28日分别召开董事会及临时股东会，审议通过回购公司股份的议案。回购进展符合相关法规及公司方案要求。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050600040225.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000950","BK0250","BK0071"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633180424","title":"重药控股最新公告：参股子公司硝普钠注射液获国家药监局注册批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2633180424","media":"证券之星","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633180424?lang=zh_cn&edition=full","pubTime":"2026-05-06 19:49","pubTimestamp":1778068191,"startTime":"0","endTime":"0","summary":"重药控股(000950.SZ)公告称，公司参股子公司重庆药友制药的硝普钠注射液获国家药品监督管理局注册批准，适应症包括高血压急症和急性心力衰竭。该药品2025年在中国境内销售额约1.12亿元，将进一步丰富产品线，但销售情况受多重因素影响，存在不确定性。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050600035173.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0071","000950","BK0250"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631555283","title":"重药控股：本次薪酬变动主要系报告期内在公司领取薪酬的董事、高级管理人员发生4人次变动所致","url":"https://stock-news.laohu8.com/highlight/detail?id=2631555283","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631555283?lang=zh_cn&edition=full","pubTime":"2026-04-29 11:33","pubTimestamp":1777433583,"startTime":"0","endTime":"0","summary":"证券之星消息，重药控股(000950)04月28日在投资者关系平台上答复投资者关心的问题。投资者提问：2025年，公司高管薪酬总额增长率远超业绩增长率，请问公司的薪酬制度合理吗，是否损害了中小股东利益？重药控股回复：本次薪酬变动主要系报告期内在公司领取薪酬的董事、高级管理人员发生4人次变动所致。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042900037357.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","BK0071","000950"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630442643","title":"重药控股：本次薪酬变动主要系报告期内在公司领取薪酬的董事、高级管理人员发生4人次变动所致","url":"https://stock-news.laohu8.com/highlight/detail?id=2630442643","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630442643?lang=zh_cn&edition=full","pubTime":"2026-04-28 09:03","pubTimestamp":1777338186,"startTime":"0","endTime":"0","summary":"证券之星消息，重药控股(000950)04月27日在投资者关系平台上答复投资者关心的问题。投资者提问：2025年，公司高管薪酬总额增长率为82.87%，而营业收入增长率只有2.34%，差额较大且远超同行，请问这合理吗？重药控股回复：本次薪酬变动主要系报告期内在公司领取薪酬的董事、高级管理人员发生4人次变动所致。感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042800027836.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000950","BK0250","BK0071"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630395435","title":"30余家药企一季报出炉：有人狂赚有人亏 行业分化加剧","url":"https://stock-news.laohu8.com/highlight/detail?id=2630395435","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630395435?lang=zh_cn&edition=full","pubTime":"2026-04-27 19:29","pubTimestamp":1777289340,"startTime":"0","endTime":"0","summary":"近日，A股医药板块迎来一季度财报密集披露期，包括阳光诺和、华东医药、重药控股、圣诺生物、我武生物、一品红、丽珠集团、浙江医药、济川药业、科源制药、千红制药等在内的超30家药企集中交出第一季度成绩单。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202604273720459429.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604273720459429.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1161","BK0187","BK0175","300723","BK0196","BK1574","301281","BK0250","000963","688621","BK0188","LU1969619763.USD","06978","600216","BK0183","LU2328871848.SGD","BK0132","002550","BK0209","BK0071","BK0216","000950","688117","BK0239","BK0028","BK0191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630351783","title":"股市必读：重药控股年报 - 第四季度单季净利润同比增长129.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630351783","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630351783?lang=zh_cn&edition=full","pubTime":"2026-04-27 02:11","pubTimestamp":1777227069,"startTime":"0","endTime":"0","summary":"股本股东变化股东户数变动截至2026年3月31日公司股东户数为5.21万户，较12月31日减少4219.0户，减幅为7.49%。2025年度内部控制审计报告致同会计师事务所对重药控股股份有限公司2025年12月31日的财务报告内部控制有效性进行了审计。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042700005062.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000950"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629677812","title":"重药控股（000950）披露2025年度涉及财务公司关联交易的存款、贷款等金融业务专项说明，4月24日股价下跌2.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629677812","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629677812?lang=zh_cn&edition=full","pubTime":"2026-04-24 17:45","pubTimestamp":1777023922,"startTime":"0","endTime":"0","summary":"重药控股于近日披露《关于重药控股股份有限公司涉及财务公司关联交易的存款、贷款等金融业务的专项说明》。公告显示，致同会计师事务所对重药控股股份有限公司2025年度通过重庆化医控股集团财务有限公司和通用技术集团财务有限责任公司开展的存款、贷款等金融业务进行了专项说明。截至2025年末，公司在财务公司存放存款余额为4,594,116,719.28元，向通用技术集团财务有限责任公司贷款余额为3,840,975,981.02元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042400053898.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","000950","BK0071"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629851880","title":"重药控股(000950.SZ)发布一季度业绩，归母净利润1.71亿元，同比增长36.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629851880","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629851880?lang=zh_cn&edition=full","pubTime":"2026-04-24 00:47","pubTimestamp":1776962832,"startTime":"0","endTime":"0","summary":"智通财经APP讯，重药控股(000950.SZ)发布2026年第一季度报告，第一季度，公司实现营业收入204.32亿元，同比下降0.87%。归属于上市公司股东的净利润1.71亿元，同比增长36.33%。归属于上市公司股东的扣除非经常性损益的净利润1.66亿元，同比增长36.35%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1433060.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"重药控股(000950.SZ)发布一季度业绩，归母净利润1.71亿元，同比增长36.33%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["000950"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626195398","title":"4月10日重药控股（000950）龙虎榜数据：机构净卖出1.29亿元（3日），北向资金净卖出789.68万元（3日）","url":"https://stock-news.laohu8.com/highlight/detail?id=2626195398","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2626195398?lang=zh_cn&edition=full","pubTime":"2026-04-10 17:14","pubTimestamp":1775812458,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2026年4月10日公布的交易公开信息显示，重药控股因连续三个交易日内，跌幅偏离值累计达到20%的证券登上龙虎榜。此次是近5个交易日内第2次上榜。截至2026年4月10日收盘，重药控股报收于6.08元，下跌1.94%，换手率7.18%，成交量124.08万手，成交额7.47亿元。从龙虎榜公布的三日买卖数据来看，机构合计净卖出1.29亿元，北向资金合计净卖出789.68万元。深股通专用、沪股通专用为北向资金的交易席位。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026041000029216.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0250","BK0071","000950"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625978919","title":"重药控股：公司按照《企业会计准则》相关规定对联营企业进行相应的会计处理","url":"https://stock-news.laohu8.com/highlight/detail?id=2625978919","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625978919?lang=zh_cn&edition=full","pubTime":"2026-04-08 16:30","pubTimestamp":1775637024,"startTime":"0","endTime":"0","summary":"证券之星消息，重药控股04月08日在投资者关系平台上答复投资者关心的问题。投资者提问：公司1.4号公众号说控股子公司药友制药的口服小分子胰高血糖素样肽-1受体激动剂已收到辉瑞支付的首付款15,000万美元，请问是否会计入公司一季报重药控股回复：公司按照《企业会计准则》相关规定对联营企业进行相应的会计处理，对于参股子公司重庆药友制药实现的利润会根据持股比例按照权益法确认相应的投资收益。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040800025082.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0071","000950","BK0250"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1781508514529,"stockEarnings":[{"period":"1week","weight":-0.0437},{"period":"1month","weight":-0.2187},{"period":"3month","weight":-0.0917},{"period":"6month","weight":-0.1451},{"period":"1year","weight":0.0386},{"period":"ytd","weight":-0.0936}],"compareEarnings":[{"period":"1week","weight":0.0009},{"period":"1month","weight":-0.0497},{"period":"3month","weight":-0.0156},{"period":"6month","weight":0.0366},{"period":"1year","weight":0.1848},{"period":"ytd","weight":0.0158}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"重药控股股份有限公司","boardCode":"AI0051","boardName":"批发业","stockholders":"52072人(较上一季度减少7.49%)","perCapita":"33188股","listingDate":"1999-09-16","address":"重庆市两江新区金石大道303号","registeredCapital":"172818万元","survey":" 重药控股股份有限公司的主营业务是医药商业、仓储物流、医药工业和研发等业务。公司的主要产品是药品、医疗器械、中药饮片、保健产品。","listedPrice":4.63},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"重药控股(000950)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供重药控股(000950)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"重药控股,000950,重药控股股票,重药控股股票老虎,重药控股股票老虎国际,重药控股行情,重药控股股票行情,重药控股股价,重药控股股市,重药控股股票价格,重药控股股票交易,重药控股股票购买,重药控股股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"重药控股(000950)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供重药控股(000950)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}